ArticleLeukemia2023

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.

Jan-Niklas Eckardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.